Topovale is a potent antineoplastic agent belonging to the benzodiazepine-naphthyridine class, developed as a tubulin polymerization inhibitor to treat various solid tumors. By disrupting microtubule dynamics… Read more
Topovale is a potent antineoplastic agent belonging to the benzodiazepine-naphthyridine class, developed as a tubulin polymerization inhibitor to treat various solid tumors. By disrupting microtubule dynamics and arresting cell division in the M phase, this compound demonstrates significant cytotoxicity against a wide panel of cancer cell lines. This category provides comprehensive reference standards for the Topovale active pharmaceutical ingredient, alongside its related impurities, metabolites, and stable isotope-labelled compounds. These high-quality materials are essential for pharmaceutical laboratories performing rigorous impurity profiling, method validation, and routine quality control. Utilizing these characterized standards enables accurate identification and quantification of degradation products or metabolic byproducts, ensuring compliance with regulatory requirements during the development and manufacturing of this antitumor therapeutic.